CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Chlorpromazine InjectionWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug324 Global Longitudinal Strain Wiki 1.00

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D009202 Cardiomyopathies NIH 0.71

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Administration of Chloropromazine as a Treatment for COVID-19

In this study, defined cases of COVID-19 confirmed with PCR, with a mild, moderate or severe pneumonia will be treated with chlorpromazine IV injection. The improvement in clinical & laboratory manifestations will be evaluated in treated patient compared to control group.

NCT04354805 COVID-19 Drug: Chlorpromazine Injection

Primary Outcomes

Description: LDH is an enzyme indicate some form of tissue damage, Normal LDH levels range from 140 units per litre (U/L) to 280 U/L.

Measure: Lactate dehydrogenase (LDH)

Time: 2 weeks


No related HPO nodes (Using clinical trials)